Market Research Life Sciences Market Research Pharmaceuticals Market Research Therapeutic Area Market Research CNS/Neurology Market Research

Global Transcranial Magnetic Stimulators (TMS) Market Insights, Forecast to 2028

Best Price Guarantee Length Publisher Published Date SKU
from $4,900 150 Pages QYResearch Group February, 2022 QYR16981998
Best Price Guarantee
Price from $4,900
Length 150 Pages
Publisher QYResearch Group
Published Date February, 2022
SKU QYR16981998

Global Transcranial Magnetic Stimulators (TMS) Market Insights, Forecast to 2028

Summary

Market Analysis and Insights: Global Erectile Dysfunction Market
Due to patent expiration of major brands, the global Erectile Dysfunction market size is estimated to be worth US$ 4.86 billion in 2021 and is forecast to a readjusted size of US$ 8.1 billion by 2028 with a CAGR of 7.04% during the review period.
China Erectile Dysfunction market size is valued at US$ 700 million in 2021, while the US and Europe Erectile Dysfunction are US$ 1917.53 million and US$ 1237.90 million, severally. The proportion of the US is 39.42% in 2021, while China and Europe are 14.41% and 25.45% respectively, and it is predicted that China proportion will reach 16.8% in 2028, trailing a CAGR of 9.06% from 2022 to 2028. Japan, Korea are noteworthy markets in Asia, with CAGR 8.29%, 7.83% respectively from 2022 to 2028. As for the Europe Erectile Dysfunction landscape, Germany is projected to reach US$ 363.35 million by 2028 trailing a CAGR of 5.45% over the forecast period.
The global key manufacturers of Erectile Dysfunction include Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, S.K. Chemicals, Teva Pharma, Dong-A ST, Petros Pharmaceuticals, and Seoul Pharma, etc. In 2021, the global top five players have a share approximately 26.57% in terms of revenue.
Global Erectile Dysfunction Scope and Segment
Erectile Dysfunction market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Erectile Dysfunction market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type, and by Application for the period 2017-2028.
By Company
Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Petros Pharmaceuticals
Seoul Pharma
Yabang Pharmacy

Segment by Type
Sildenafil
Tadalafil
Others

Segment by Application
Hospital Pharmacies
Private Clinics
Retail Pharmacies
E-Commerce (B2B)
E-Commerce (B2C)

Segment by Region
North America
United States
Canada
Mexico

Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia

Europe
Germany
France
U.K.
Italy
Russia

Latin America
Brazil
Argentina

Middle East & Africa
Turkey
Saudi Arabia
UAE
Egypt


1 STUDY COVERAGE
1.1 Erectile Dysfunction Product Introduction
1.2 Market by Type
1.2.1 Global Erectile Dysfunction Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Sildenafil
1.2.3 Tadalafil
1.2.4 Others
1.3 Market by Application
1.3.1 Global Erectile Dysfunction Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Private Clinics
1.3.4 Retail Pharmacies
1.3.5 E-Commerce (B2B)
1.3.6 E-Commerce (B2C)
1.4 Study Objectives
1.5 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Erectile Dysfunction Sales Estimates and Forecasts 2017-2028
2.2 Global Erectile Dysfunction Revenue Estimates and Forecasts 2017-2028
2.3 Global Erectile Dysfunction Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Erectile Dysfunction Sales by Region
2.4.1 Global Erectile Dysfunction Sales by Region (2017-2022)
2.4.2 Global Sales Erectile Dysfunction by Region (2023-2028)
2.5 Global Erectile Dysfunction Revenue by Region
2.5.1 Global Erectile Dysfunction Revenue by Region (2017-2022)
2.5.2 Global Erectile Dysfunction Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 COMPETITION BY MANUFACTURERS
3.1 Global Erectile Dysfunction Sales by Manufacturers
3.1.1 Global Erectile Dysfunction Sales by Manufacturers (2017-2022)
3.1.2 Global Erectile Dysfunction Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 3 and Top 5 Largest Manufacturers of Erectile Dysfunction in 2021
3.2 Global Erectile Dysfunction Revenue by Manufacturers
3.2.1 Global Erectile Dysfunction Revenue by Manufacturers (2017-2022)
3.2.2 Global Erectile Dysfunction Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 3 and Top 5 Companies by Erectile Dysfunction Revenue in 2021
3.3 Global Erectile Dysfunction Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Erectile Dysfunction Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Erectile Dysfunction Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 MARKET SIZE BY TYPE
4.1 Global Erectile Dysfunction Sales by Type
4.1.1 Global Erectile Dysfunction Historical Sales by Type (2017-2022)
4.1.2 Global Erectile Dysfunction Forecasted Sales by Type (2023-2028)
4.1.3 Global Erectile Dysfunction Sales Market Share by Type (2017-2028)
4.2 Global Erectile Dysfunction Revenue by Type
4.2.1 Global Erectile Dysfunction Historical Revenue by Type (2017-2022)
4.2.2 Global Erectile Dysfunction Forecasted Revenue by Type (2023-2028)
4.2.3 Global Erectile Dysfunction Revenue Market Share by Type (2017-2028)
4.3 Global Erectile Dysfunction Price by Type
4.3.1 Global Erectile Dysfunction Price by Type (2017-2022)
4.3.2 Global Erectile Dysfunction Price Forecast by Type (2023-2028)
5 MARKET SIZE BY APPLICATION
5.1 Global Erectile Dysfunction Sales by Application
5.1.1 Global Erectile Dysfunction Historical Sales by Application (2017-2022)
5.1.2 Global Erectile Dysfunction Forecasted Sales by Application (2023-2028)
5.1.3 Global Erectile Dysfunction Sales Market Share by Application (2017-2028)
5.2 Global Erectile Dysfunction Revenue by Application
5.2.1 Global Erectile Dysfunction Historical Revenue by Application (2017-2022)
5.2.2 Global Erectile Dysfunction Forecasted Revenue by Application (2023-2028)
5.2.3 Global Erectile Dysfunction Revenue Market Share by Application (2017-2028)
5.3 Global Erectile Dysfunction Price by Application
5.3.1 Global Erectile Dysfunction Price by Application (2017-2022)
5.3.2 Global Erectile Dysfunction Price Forecast by Application (2023-2028)
6 NORTH AMERICA
6.1 North America Erectile Dysfunction Market Size by Type
6.1.1 North America Erectile Dysfunction Sales by Type (2017-2028)
6.1.2 North America Erectile Dysfunction Revenue by Type (2017-2028)
6.2 North America Erectile Dysfunction Market Size by Application
6.2.1 North America Erectile Dysfunction Sales by Application (2017-2028)
6.2.2 North America Erectile Dysfunction Revenue by Application (2017-2028)
6.3 North America Erectile Dysfunction Sales by Country
6.3.1 North America Erectile Dysfunction Sales by Country (2017-2028)
6.3.2 North America Erectile Dysfunction Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 EUROPE
7.1 Europe Erectile Dysfunction Market Size by Type
7.1.1 Europe Erectile Dysfunction Sales by Type (2017-2028)
7.1.2 Europe Erectile Dysfunction Revenue by Type (2017-2028)
7.2 Europe Erectile Dysfunction Market Size by Application
7.2.1 Europe Erectile Dysfunction Sales by Application (2017-2028)
7.2.2 Europe Erectile Dysfunction Revenue by Application (2017-2028)
7.3 Europe Erectile Dysfunction Market Size by Country
7.3.1 Europe Erectile Dysfunction Sales by Country (2017-2028)
7.3.2 Europe Erectile Dysfunction Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 ASIA PACIFIC
8.1 Asia Pacific Erectile Dysfunction Market Size by Type
8.1.1 Asia Pacific Erectile Dysfunction Sales by Type (2017-2028)
8.1.2 Asia Pacific Erectile Dysfunction Revenue by Type (2017-2028)
8.2 Asia Pacific Erectile Dysfunction Market Size by Application
8.2.1 Asia Pacific Erectile Dysfunction Sales by Application (2017-2028)
8.2.2 Asia Pacific Erectile Dysfunction Revenue by Application (2017-2028)
8.3 Asia Pacific Erectile Dysfunction Market Size by Region
8.3.1 Asia Pacific Erectile Dysfunction Sales by Region (2017-2028)
8.3.2 Asia Pacific Erectile Dysfunction Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 LATIN AMERICA
9.1 Latin America Erectile Dysfunction Market Size by Type
9.1.1 Latin America Erectile Dysfunction Sales by Type (2017-2028)
9.1.2 Latin America Erectile Dysfunction Revenue by Type (2017-2028)
9.2 Latin America Erectile Dysfunction Market Size by Application
9.2.1 Latin America Erectile Dysfunction Sales by Application (2017-2028)
9.2.2 Latin America Erectile Dysfunction Revenue by Application (2017-2028)
9.3 Latin America Erectile Dysfunction Market Size by Country
9.3.1 Latin America Erectile Dysfunction Sales by Country (2017-2028)
9.3.2 Latin America Erectile Dysfunction Revenue by Country (2017-2028)
9.3.3 Brazil
9.3.4 Argentina
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Erectile Dysfunction Market Size by Type
10.1.1 Middle East and Africa Erectile Dysfunction Sales by Type (2017-2028)
10.1.2 Middle East and Africa Erectile Dysfunction Revenue by Type (2017-2028)
10.2 Middle East and Africa Erectile Dysfunction Market Size by Application
10.2.1 Middle East and Africa Erectile Dysfunction Sales by Application (2017-2028)
10.2.2 Middle East and Africa Erectile Dysfunction Revenue by Application (2017-2028)
10.3 Middle East and Africa Erectile Dysfunction Market Size by Country
10.3.1 Middle East and Africa Erectile Dysfunction Sales by Country (2017-2028)
10.3.2 Middle East and Africa Erectile Dysfunction Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 UAE
11 CORPORATE PROFILE
11.1 Eli Lilly
11.1.1 Eli Lilly Corporation Information
11.1.2 Eli Lilly Overview
11.1.3 Eli Lilly Erectile Dysfunction Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Eli Lilly Erectile Dysfunction Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Eli Lilly Recent Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Erectile Dysfunction Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Pfizer Erectile Dysfunction Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Bayer
11.3.1 Bayer Corporation Information
11.3.2 Bayer Overview
11.3.3 Bayer Erectile Dysfunction Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Bayer Erectile Dysfunction Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bayer Recent Developments
11.4 BaiYunShan General Factory
11.4.1 BaiYunShan General Factory Corporation Information
11.4.2 BaiYunShan General Factory Overview
11.4.3 BaiYunShan General Factory Erectile Dysfunction Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 BaiYunShan General Factory Erectile Dysfunction Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 BaiYunShan General Factory Recent Developments
11.5 S.K. Chemicals
11.5.1 S.K. Chemicals Corporation Information
11.5.2 S.K. Chemicals Overview
11.5.3 S.K. Chemicals Erectile Dysfunction Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 S.K. Chemicals Erectile Dysfunction Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 S.K. Chemicals Recent Developments
11.6 Teva Pharma
11.6.1 Teva Pharma Corporation Information
11.6.2 Teva Pharma Overview
11.6.3 Teva Pharma Erectile Dysfunction Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Teva Pharma Erectile Dysfunction Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Teva Pharma Recent Developments
11.7 Dong-A ST
11.7.1 Dong-A ST Corporation Information
11.7.2 Dong-A ST Overview
11.7.3 Dong-A ST Erectile Dysfunction Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Dong-A ST Erectile Dysfunction Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Dong-A ST Recent Developments
11.8 Petros Pharmaceuticals
11.8.1 Petros Pharmaceuticals Corporation Information
11.8.2 Petros Pharmaceuticals Overview
11.8.3 Petros Pharmaceuticals Erectile Dysfunction Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Petros Pharmaceuticals Erectile Dysfunction Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Petros Pharmaceuticals Recent Developments
11.9 Seoul Pharma
11.9.1 Seoul Pharma Corporation Information
11.9.2 Seoul Pharma Overview
11.9.3 Seoul Pharma Erectile Dysfunction Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Seoul Pharma Erectile Dysfunction Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Seoul Pharma Recent Developments
11.10 Yabang Pharmacy
11.10.1 Yabang Pharmacy Corporation Information
11.10.2 Yabang Pharmacy Overview
11.10.3 Yabang Pharmacy Erectile Dysfunction Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Yabang Pharmacy Erectile Dysfunction Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Yabang Pharmacy Recent Developments
12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
12.1 Erectile Dysfunction Industry Chain Analysis
12.2 Erectile Dysfunction Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Erectile Dysfunction Production Mode & Process
12.4 Erectile Dysfunction Sales and Marketing
12.4.1 Erectile Dysfunction Sales Channels
12.4.2 Erectile Dysfunction Distributors
12.5 Erectile Dysfunction Customers
13 ERECTILE DYSFUNCTION MARKET DYNAMICS
13.1.1 Erectile Dysfunction Industry Trends
13.1.2 Erectile Dysfunction Market Drivers
13.1.3 Erectile Dysfunction Market Challenges
13.1.4 Erectile Dysfunction Market Restraints
14 KEY FINDINGS IN THE GLOBAL ERECTILE DYSFUNCTION STUDY
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Erectile Dysfunction Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Tadalafil
Table 3. Major Manufacturers of Others
Table 4. Global Erectile Dysfunction Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Erectile Dysfunction Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Erectile Dysfunction Sales by Region (2017-2022) & (M Pill)
Table 7. Global Erectile Dysfunction Sales Market Share by Region (2017-2022)
Table 8. Global Erectile Dysfunction Sales by Region (2023-2028) & (M Pill)
Table 9. Global Erectile Dysfunction Sales Market Share by Region (2023-2028)
Table 10. Global Erectile Dysfunction Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Erectile Dysfunction Revenue Market Share by Region (2017-2022)
Table 12. Global Erectile Dysfunction Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Erectile Dysfunction Revenue Market Share by Region (2023-2028)
Table 14. Global Erectile Dysfunction Sales by Manufacturers (2017-2022) & (M Pill)
Table 15. Global Erectile Dysfunction Sales Share by Manufacturers (2017-2022)
Table 16. Global Erectile Dysfunction Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Erectile Dysfunction Revenue Market Share by Manufacturers (2017-2022)
Table 18. Erectile Dysfunction Price by Manufacturers (2017-2022) & (US$/Pill)
Table 19. Global Erectile Dysfunction Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Erectile Dysfunction by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Erectile Dysfunction as of 2021)
Table 21. Erectile Dysfunction Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Erectile Dysfunction Product Offered
Table 23. Date of Manufacturers Enter into Erectile Dysfunction Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Erectile Dysfunction Sales by Type (2017-2022) & (M Pill)
Table 26. Global Erectile Dysfunction Sales by Type (2023-2028) & (M Pill)
Table 27. Global Erectile Dysfunction Sales Share by Type (2017-2022)
Table 28. Global Erectile Dysfunction Sales Share by Type (2023-2028)
Table 29. Global Erectile Dysfunction Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Erectile Dysfunction Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Erectile Dysfunction Revenue Share by Type (2017-2022)
Table 32. Global Erectile Dysfunction Revenue Share by Type (2023-2028)
Table 33. Erectile Dysfunction Price by Type (2017-2022) & (US$/Pill)
Table 34. Global Erectile Dysfunction Price Forecast by Type (2023-2028) & (US$/Pill)
Table 35. Global Erectile Dysfunction Sales by Application (2017-2022) & (M Pill)
Table 36. Global Erectile Dysfunction Sales by Application (2023-2028) & (M Pill)
Table 37. Global Erectile Dysfunction Sales Share by Application (2017-2022)
Table 38. Global Erectile Dysfunction Sales Share by Application (2023-2028)
Table 39. Global Erectile Dysfunction Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Erectile Dysfunction Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Erectile Dysfunction Revenue Share by Application (2017-2022)
Table 42. Global Erectile Dysfunction Revenue Share by Application (2023-2028)
Table 43. Erectile Dysfunction Price by Application (2017-2022) & (US$/Pill)
Table 44. Global Erectile Dysfunction Price Forecast by Application (2023-2028) & (US$/Pill)
Table 45. North America Erectile Dysfunction Sales by Type (2017-2022) & (M Pill)
Table 46. North America Erectile Dysfunction Sales by Type (2023-2028) & (M Pill)
Table 47. North America Erectile Dysfunction Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Erectile Dysfunction Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Erectile Dysfunction Sales by Application (2017-2022) & (M Pill)
Table 50. North America Erectile Dysfunction Sales by Application (2023-2028) & (M Pill)
Table 51. North America Erectile Dysfunction Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Erectile Dysfunction Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Erectile Dysfunction Sales by Country (2017-2022) & (M Pill)
Table 54. North America Erectile Dysfunction Sales by Country (2023-2028) & (M Pill)
Table 55. North America Erectile Dysfunction Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Erectile Dysfunction Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Erectile Dysfunction Sales by Type (2017-2022) & (M Pill)
Table 58. Europe Erectile Dysfunction Sales by Type (2023-2028) & (M Pill)
Table 59. Europe Erectile Dysfunction Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Erectile Dysfunction Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Erectile Dysfunction Sales by Application (2017-2022) & (M Pill)
Table 62. Europe Erectile Dysfunction Sales by Application (2023-2028) & (M Pill)
Table 63. Europe Erectile Dysfunction Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Erectile Dysfunction Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Erectile Dysfunction Sales by Country (2017-2022) & (M Pill)
Table 66. Europe Erectile Dysfunction Sales by Country (2023-2028) & (M Pill)
Table 67. Europe Erectile Dysfunction Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Erectile Dysfunction Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Erectile Dysfunction Sales by Type (2017-2022) & (M Pill)
Table 70. Asia Pacific Erectile Dysfunction Sales by Type (2023-2028) & (M Pill)
Table 71. Asia Pacific Erectile Dysfunction Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Erectile Dysfunction Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Erectile Dysfunction Sales by Application (2017-2022) & (M Pill)
Table 74. Asia Pacific Erectile Dysfunction Sales by Application (2023-2028) & (M Pill)
Table 75. Asia Pacific Erectile Dysfunction Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Erectile Dysfunction Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Erectile Dysfunction Sales by Region (2017-2022) & (M Pill)
Table 78. Asia Pacific Erectile Dysfunction Sales by Region (2023-2028) & (M Pill)
Table 79. Asia Pacific Erectile Dysfunction Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Erectile Dysfunction Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Erectile Dysfunction Sales by Type (2017-2022) & (M Pill)
Table 82. Latin America Erectile Dysfunction Sales by Type (2023-2028) & (M Pill)
Table 83. Latin America Erectile Dysfunction Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Erectile Dysfunction Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Erectile Dysfunction Sales by Application (2017-2022) & (M Pill)
Table 86. Latin America Erectile Dysfunction Sales by Application (2023-2028) & (M Pill)
Table 87. Latin America Erectile Dysfunction Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Erectile Dysfunction Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Erectile Dysfunction Sales by Country (2017-2022) & (M Pill)

$4,900
$9,800

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings